Immunstimulating lipid formulation

Abstract

A pharmaceutical formulation for parenteral or mucosal administration of antigens and/or vaccines to humans and animals, comprising monglyceride preparations having at least 80% monoglyceride content and where the acyl group contains from 6 to 24 carbon atoms, together with fatty acids where the number of carbon atoms may be varied between 4 and 22.

1 - 15 . (canceled)  
     
     
         16 . A method of immunizing a human or animal, the method comprising administering to a human or animal by mucosal administration a vaccine composition comprising an adjuvant component comprising: 
 I) monoglyceride;    ii) fatty acid; and,    iii) water,    wherein the percent weight ratio of monoglyceride and fatty acid is between 10 to 90 together with an immunogenic quantity of an antigen component selected from the group consisting of diphtheria toxoid, influenza and rota virus antigen.